Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 32 (November 10), 2007: pp. 5106-5112
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.12.2341

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Publisher's Note
Right arrow Erratum (v26,p1018)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, S. F.
Right arrow Articles by Weinfurt, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, S. F.
Right arrow Articles by Weinfurt, K.

REVIEW ARTICLE

Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative

Sofia F. Garcia, David Cella, Steven B. Clauser, Kathryn E. Flynn, Thomas Lad, Jin-Shei Lai, Bryce B. Reeve, Ashley Wilder Smith, Arthur A. Stone, Kevin Weinfurt

From the Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, Evanston; Department of Psychiatry and Behavioral Sciences, Institute for Healthcare Studies, and Department of Pediatrics, Feinberg School of Medicine, Northwestern University; Hematology/Oncology Division, Stronger Hospital of Cook County, Chicago, IL; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Center for Clinical and Genetic Economics, Duke Clinical Research Institute; Departments of Psychiatry and Behavioral Sciences and Psychology and Neuroscience, Duke University, Durham, NC; and Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY

Address reprint requests to David Cella, PhD, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare, 1001 University Pl, Suite 100, Evanston, Illinois 60201; e-mail: d-cella{at}northwestern.edu

Patient-reported outcomes (PROs), such as symptom scales or more broad-based health-related quality-of-life measures, play an important role in oncology clinical trials. They frequently are used to help evaluate cancer treatments, as well as for supportive and palliative oncology care. To be most beneficial, these PROs must be relevant to patients and clinicians, valid, and easily understood and interpreted. The Patient-Reported Outcomes Measurement Information System (PROMIS) Network, part of the National Institutes of Health Roadmap Initiative, aims to improve appreciably how PROs are selected and assessed in clinical research, including clinical trials. PROMIS is establishing a publicly available resource of standardized, accurate, and efficient PRO measures of major self-reported health domains (eg, pain, fatigue, emotional distress, physical function, social function) that are relevant across chronic illnesses including cancer. PROMIS is also developing measures of self-reported health domains specifically targeted to cancer, such as sleep/wake function, sexual function, cognitive function, and the psychosocial impacts of the illness experience (ie, stress response and coping; shifts in self-concept, social interactions, and spirituality). We outline the qualitative and quantitative methods by which PROMIS measures are being developed and adapted for use in clinical oncology research. At the core of this activity is the formation and application of item banks using item response theory modeling. We also present our work in the fatigue domain, including a short-form measure, as a sample of PROMIS methodology and work to date. Plans for future validation and application of PROMIS measures are discussed.

Supported by National Institutes of Health Grant No. U01AR052177 to the Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, and Grant No. U01AR052186 to Duke University Medical Center. In addition to financial support, the sponsor reviewed and approved the study design and monitored its progress and results.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
JCOHome page
S. B. Clauser, P. A. Ganz, J. Lipscomb, and B. B. Reeve
Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making
J. Clin. Oncol., November 10, 2007; 25(32): 5049 - 5050.
[Full Text] [PDF]


Home page
JCOHome page
J. Lipscomb, B. B. Reeve, S. B. Clauser, J. S. Abrams, D. Watkins Bruner, L. B. Burke, A. M. Denicoff, P. A. Ganz, K. Gondek, L. M. Minasian, et al.
Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward
J. Clin. Oncol., November 10, 2007; 25(32): 5133 - 5140.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online